Full Press Release Details
Axsome Therapeutics Presents New Data from the EVOLVE Open Label Trial Demonstrating Effects of AUVELITY on Cognitive and Physical Functioning in Patients with Major Depressive Dis.
AXSM
Axsome Therapeutics Presents New Data from the EVOLVE Open Label Trial Demonstrating Effects of AUVELITY on Cognitive and Physical Functioning in Patients with Major Depressive Dis
Key Takeaway: Axsome Therapeutics Presents New Data from the EVOLVE Open Label Trial Demonstrating Effects of AUVELITY on Cognitive and Physical Functioning in Patients with Major Depressive Dis